HLA polymorphisms as incidence factor in the progression to end-stage renal disease in Brazilian patients awaiting kidney transplant


Autoria(s): CRISPIM, J. C.; MENDES-JUNIOR, C. T.; WASTOWSKI, I. J.; PALOMINO, G. Martelli; SABER, L. T.; RASSI, D. M.; DONADI, E. A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

Chronic renal failure (CRF) leads in the majority of instances to end-stage renal disease (ESRD) requiring renal replacement therapy. Age, gender, genetics, race, hypertension, and smoking among others are factors associated with ESRD. Our interest was to evaluate the possible associations of class I and II HLA antigens with ESRD renal disease independent of other factors, among patients with CRF, having various diagnoses in the Brazilian population of the Sao Paulo state. So 21 HLA-A, 31 HLA-B, and 13 HLA-DR were detected in 105 patients who were compared with 160 healthy controls of both sexes who were not related to the patients evaluated until 2005. We calculated allelic frequencies, haplotypes frequencies, etiological fractions (EF), preventive fractions, and relative risks (RR). We compared demographic data of patients and controls. The antigens positively associated with ESRD were: HLA-A78 (RR = 30.31 and EF = 0.96) and HLA-DR11 (RR = 18.87 and EF = 0.65). The antigens HLAB14 (RR = 29.90 and EF = 0.75) was present at a significantly lower frequency among patients compared with controls. In contrast, no haplotype frequency showed statically significant associations. Further molecular studies may clarify types and subtypes of alleles involved with ESRD progression.

Identificador

TRANSPLANTATION PROCEEDINGS, v.40, n.5, p.1333-1336, 2008

0041-1345

http://producao.usp.br/handle/BDPI/24042

10.1016/j.transproceed.2008.02.086

http://dx.doi.org/10.1016/j.transproceed.2008.02.086

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE INC

Relação

Transplantation Proceedings

Direitos

restrictedAccess

Copyright ELSEVIER SCIENCE INC

Palavras-Chave #IGA NEPHROPATHY #GENE #Immunology #Surgery #Transplantation
Tipo

article

original article

publishedVersion